Your browser doesn't support javascript.
loading
Treatment of eosinophilic meningitis with a combination of albendazole and corticosteroid.
Article de En | IMSEAR | ID: sea-33444
To study the efficacy of the combination of albendazole and prednisolone for the treatment of eosinophilic meningitis, we conducted a pilot study among Thai patients with eosinophilic meningitis. Patients were given a 2-week course of prednisolone, 60 mg/day and albendazole, 15 mg/kg/ day. The primary observation parameter was the number of patients who still had headache after the 2-week course of treatment. Twenty-six patients were enrolled in the study. There were 3 (11.5%) patients who still had headache after the 2-week course of treatment and the median length of time until complete disappearance of headache was 4 days. Serious side effects were not detected. Treatment for 2 weeks with the combination regimen of albendazole and prednisolone is safe and effective for the treatment of eosinophilic meningitis.
Sujet(s)
Texte intégral: 1 Indice: IMSEAR Sujet Principal: Thaïlande / Indice de gravité de la maladie / Femelle / Humains / Mâle / Calendrier d'administration des médicaments / Prednisolone / Albendazole / Administration par voie orale / Études prospectives Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Pays comme sujet: Asia langue: En Texte intégral: Southeast Asian J Trop Med Public Health Année: 2004 Type: Article
Texte intégral: 1 Indice: IMSEAR Sujet Principal: Thaïlande / Indice de gravité de la maladie / Femelle / Humains / Mâle / Calendrier d'administration des médicaments / Prednisolone / Albendazole / Administration par voie orale / Études prospectives Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Pays comme sujet: Asia langue: En Texte intégral: Southeast Asian J Trop Med Public Health Année: 2004 Type: Article